Experiences With Detection of Higher‐Copy Sex Chromosome Aneuploidy by cfDNA Screening: The Critical Role of Diagnostic Testing
American Journal of Medical Genetics Part A · 2026-08 · 200 (8) · 1846-1849
DOI: 10.1002/ajmg.a.70132 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 17.03.2026. Verfasst von Lauren A Choate und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cytogenetics, Center for Advanced Molecular Diagnostics, Department of Pathology, Harvard Medical School and Brigham and Women's Hospital…. Hauptthemen laut MEDLINE: Aneuploidy, Cell-Free Nucleic Acids, Sex Chromosomes, Sex Chromosome Aberrations. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Noninvasive prenatal cell‐free DNA (cfDNA) screening is standard of care for detecting prenatal chromosomal aneuploidies. The positive predictive value of prenatal cfDNA screening is lower for sex chromosome aneuploidies (SCAs) compared to autosomal aneuploidies due to sex chromosome mosaicism and the potential for subclinical maternal sex chromosome aneuploidy. In some cases, these factors can result in indeterminate cfDNA results for SCAs. We present three cases which highlight higher‐copy sex chromosome aneuploidies (HC SCAs; i.e., tetrasomy and pentasomy for the sex chromosomes) as one cause of an indeterminate sex chromosome prenatal cfDNA result. Timely diagnosis of HC SCAs enables informed pregnancy management and decision‐making. Thus, these cases underscore the potential value of an indeterminate result by cfDNA screening and the importance of comprehensive genetic counseling and follow‐up diagnostic testing when faced with indeterminate cfDNA results, particularly regarding the risk of HC SCAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cytogenetics, Center for Advanced Molecular Diagnostics, Department of Pathology, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Division of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts, USA.
- Myriad Genetic Laboratories, Inc., Salt Lake City, Utah, USA.
ORCID-Profile: Lauren A Choate
Zitieren
APA
Choate, L. A., Studwell, C., Miller, D. T., Giersch, A. B., Schilit, S. L. P., & Mason-Suares, H. M. (2026). Experiences With Detection of Higher‐Copy Sex Chromosome Aneuploidy by cfDNA Screening: The Critical Role of Diagnostic Testing. American Journal of Medical Genetics Part A, 200(8), 1846-1849. https://doi.org/10.1002/ajmg.a.70132
Vancouver
Choate LA, Studwell C, Miller DT, Giersch AB, Schilit SLP, Mason-Suares HM. Experiences With Detection of Higher‐Copy Sex Chromosome Aneuploidy by cfDNA Screening: The Critical Role of Diagnostic Testing. American Journal of Medical Genetics Part A. 2026;200(8):1846-1849. doi:10.1002/ajmg.a.70132
BibTeX
@article{Choate2026,
author = {Choate, Lauren A and Studwell, Courtney and Miller, David T and Giersch, Anne B and Schilit, Samantha L P and Mason-Suares, Heather M},
title = {Experiences With Detection of Higher‐Copy Sex Chromosome Aneuploidy by cfDNA Screening: The Critical Role of Diagnostic Testing},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
volume = {200},
number = {8},
pages = {1846--1849},
doi = {10.1002/ajmg.a.70132}
}
EUVIMED